ARTICLE | Company News
Oxford BioMedica extends Aventis deal
June 6, 2000 7:00 AM UTC
BioMedica (LSE:OXB) extended its deal with AVE to include access to OXB's LentiVector lentiviral gene delivery vector for cardiovascular disease. AVE also exercised its option under the 1998 deal to i...